Dr. Noubar Afeyan is founder and CEO of Flagship Pioneering, a company that creates bioplatform companies to transform human health and sustainability.
An entrepreneur and biochemical engineer, Dr. Afeyan holds more than 100 patents and has co-founded more than 70 life science and technology startups during his 35-year career.
He is co-founder and chairman of the board of Moderna, the pioneering messenger RNA company addressing the global COVID-19 pandemic through life-saving vaccines.
Noubar entered biotechnology during its emergence as an academic field and industry, completing his doctoral work in biochemical engineering at MIT in 1987.
He teaches and speaks around the world on topics ranging from entrepreneurship, innovation, and economic development to biological engineering, new medicines, and renewable energy.
Dr. Afeyan has received multiple awards for his passionate advocacy of the contributions of immigrants to economic and scientific progress. He is the co-founder of the Aurora Prize for Awakening Humanity and a number of other philanthropic projects focused on Armenia.
He founded Flagship Pioneering, a company that designs, nurtures, and develops companies that are leading life science platforms capable of transforming human health and prolonging life expectancy.
It holds over 100 patents, and founded the pioneering messenger RNA vaccine company Moderna that is fighting the global COVID-19 pandemic.
Passionate about sports and very dedicated to the development of to Armenia through various initiatives, he brought his personal – and precious – support to Sardarapat Football Club since its creation.
Bachelor’s degree in chemical engineering (Canada)
Doctorate in biochemical engineering at M.I.T (USA)